The board of directors of
Abbott ABT today declared its 356^th consecutive quarterly cash
dividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, to
shareholders of record on Jan. 15, 2013. The management of AbbVie, Abbott's
research-based pharmaceuticals business, intends to recommend a cash dividend,
subject to AbbVie board approval, of $0.40 per share, which together with
Abbott's dividend will equal a cash dividend of $0.54 per share, an increase
of nearly 6 percent over Abbott's quarterly cash dividend declared in
September 2012.
Abbott's annualized cash dividend of $0.56 per share, combined with AbbVie's
annualized cash dividend of $1.60 per share equals a total annualized cash
dividend of $2.16 per share, compared to the annualized cash dividend of
Abbott, prior to separation, of $2.04 per share. Future quarterly dividends,
including the expected AbbVie dividend in February 2013, are subject to
approval by each company's board of directors.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in